EuroCVP 2021 was held online which gave another dimension to our event.
This year, the programme was organised into sessions, moving through the different stages and issues patients born with congenital heart disease face as they survive to adulthood.
Participants were able to attend rapid-fire sessions, case-based symposia and debates to allow intense interaction between the audience and experts in various fields of congenital cardiology and also in-depth discussion of ongoing questions.
Thank you for attending EuroCVP 2021.
From the Committee
In this unusual year in which many scientific conferences have been cancelled or switched from face-to-face meetings to virtual meetings due to the coronavirus pandemic, the ESC Working Group on Cardiovascular Pharmacotherapy was pleased to organise the virtual edition of the EuroCVP 2021.
In edition to this, the programme's main sessions dealt with all of the most recent updates in the field, including a focus on pharmacotherapy and covid-19 (session 10), current challenges in pharmacogenomics (session 3), how to manage post-operative anti-thrombotic therapy after cardiovascular surgery (session 4)...
The scientific committee comprised the following members of the nucleus of the ESC Working Group on Cardiovascular Pharmacotherapy
Dr. Patrick Sulzgruber, Course Coordinator
Prof. Alexander Niessner, Austria, WG Chairperson
Prof. Heinz Drexel, Austria, WG Past Chairperson
Prof. Juan Carlos Kaski, UK, WG Chairperson-Elect
Prof. Sven Wassmann, Germany
Prof. Gianluigi Savarese, Sweden
Prof. Juan Tamargo, Spain
Become a member
This course is organised by the ESC Working Group on Cardiovascular Pharmacotherapy.
Not a member yet? Join today for free
Plaza de Europa, 17-19
08908 L’Hospitalet de Llobregat
Please do not hesitate to contact the ESC Working Groups department for more information.